An adult case of severe life-threatening Mycoplasma pneumoniae pneumonia due to a macrolide-resistant strain, Japan: a case report.

Munehiro MatsumotoKentaro NagaokaMasaru SuzukiSatoshi KonnoKei TakahashiTaichi TakashinaNobuhisa IshiguroMasaharu Nishimura

Published in: BMC infectious diseases (2019)

More awareness is needed on the emergence of macrolide-resistant MP infection in adults, because severe infection could develop despite initial treatment with macrolide and steroid therapy, which are generally considered as standard therapy for MP.

Keyphrases

early onset
respiratory tract
drug induced
mesenchymal stem cells
bone marrow
extracorporeal membrane oxygenation